Scipher Medicine is pivoting from solely providing molecular diagnostics for rheumatoid arthritis to advancing data-driven precision medicine development across non-oncology diseases. Under CEO Reg Seeto, the company leverages the world’s largest non-oncology transcriptomic dataset and has entered multiple partnerships to build clinicogenomic datasets, such as with Savant Bio. These efforts aim to enhance biomarker discovery and therapeutic development by correlating transcriptomics with clinical histories through advanced data extraction methodologies, mirroring strategies successful in oncology diagnostics and drug discovery.